Exploration of the potential association between GLP-1 receptor agonists and suicidal or self-injurious behaviors: a pharmacovigilance study based on the FDA Adverse Event Reporting System database
Zhou J, Zheng Y, Xu B, et al.
BMC Med. 2024;22(1):65.
Leggi